Facebook Linkedin Twitter
Inside Precision Medicine AbbVie Acquires Aliada and Alzheimer’s Candidate for $1.4B 

AbbVie

Nerve cells affected by Alzheimer's disease, which may involve abnormal microglia cells.
News & Features

AbbVie Acquires Aliada and Alzheimer’s Candidate for $1.4B 

0
Multicultural society and international tolerance, african, asian, american and caucasian culture integration and pride
News & Features

Why Equity Needs to Become Obligatory

Anita Chakraverty
0
Stomach Ache Problem
News & Features

AbbVie Pays $250M for Celsius and Its Lead Anti-TREM1 Antibody for IBD

0
DNA molecular structure and data
News & Features

FDA’s Rare Disease START Program Selects Calico Drug, and Several More

0
Diseased colon, illustration
News & Features

AbbVie Pumps up Autoimmune Portfolio by Acquiring Landos

0
Multiple Sclerosis Nerve Disorder illustrated as a head with neurons fluorescing in the brain and damaged neurons to the right hand side
News & Features

SEQSTER Chosen to Drive Forward MS Care

0
Digital Brain hovering above a series of computer chips to illustrate artificial intelligence (AI)-powered tools to help Tevogen Bio develop new T cell therapies
News & Features

AbbVie Acquires Neuroscience Shop Cerevel for $8.7B

0
Cancer cell surrounded by therapeutic antibodies and cytokines among normal cells
News & Features

AbbVie Buys ImmunoGen for $10.1B to Speed Entry into Ovarian Cancer and Other Solid Tumors

0
Lymphocyte, closeup view of T-cell or B-cell
News & Features

AbbVie Taps Immunome to Discover as Many as 10 Oncology Targets

0
Businessman showing stop sign
News & Features

Alpine Immune Sciences Terminates Oncology Trials after Second Patient Death

0
12Page 1 of 2

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine